Two Sigma Securities’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$510K Buy
+5,643
New +$330K 0.04% 608
2025
Q4
– Sell
-13,431
Closed -$157K – 2027
2025
Q3
$157K Buy
+13,431
New +$175K 0.02% 853
2024
Q1
– Sell
-3,594
Closed -$201K – 3670
2023
Q4
$201K Buy
+3,594
New +$156K ﹤0.01% 2403
2022
Q4
– Sell
-9,948
Closed -$283K – 3277
2022
Q3
$283K Buy
+9,948
New +$379K 0.01% 1635
2022
Q1
– Sell
-3,162
Closed -$277K – 2522
2021
Q4
$471K Buy
+3,162
New +$484K 0.02% 557
2021
Q3
– Sell
-1,337
Closed -$262K – 1965
2021
Q2
$262K Buy
+1,337
New +$242K 0.01% 1092
2020
Q1
– Sell
-3,895
Closed -$297K – 2327
2019
Q4
$297K Buy
+3,895
New +$234K ﹤0.01% 1795

Other funds holding TXG

Two Sigma Securities's TXG Position: Q3 2026 in Review

Two Sigma Securities opened a new position in 10x Genomics (TXG) in Q3 2026: 5,643 shares worth $510K. The stake represents 0.04% of the portfolio and ranks #608 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TXG as recently as Q3 2025.

Two Sigma Securities first reported a position in TXG in Q4 2019 and has held it in 7 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Two Sigma Securities held 5,643 shares of 10x Genomics worth $510K as of Q3 2026.
  • 10x Genomics was a new Two Sigma Securities position in Q3 2026.
  • 10x Genomics made up 0.04% of Two Sigma Securities's portfolio in Q3 2026, its #608 holding.
  • Two Sigma Securities first reported a position in 10x Genomics in Q4 2019 and has held it in 7 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.